• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角蛋白 19 与 GSK3β 相互作用,调节其核内积累和细胞周期蛋白 D3 的降解。

Keratin 19 interacts with GSK3β to regulate its nuclear accumulation and degradation of cyclin D3.

机构信息

Department of Biology, The Catholic University of America, Washington, DC 20064.

Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21231.

出版信息

Mol Biol Cell. 2021 Nov 1;32(21):ar21. doi: 10.1091/mbc.E21-05-0255. Epub 2021 Aug 18.

DOI:10.1091/mbc.E21-05-0255
PMID:34406791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8693971/
Abstract

Cyclin D3 regulates the G1/S transition and is frequently overexpressed in several cancer types including breast cancer, where it promotes tumor progression. Here we show that a cytoskeletal protein keratin 19 (K19) physically interacts with a serine/threonine kinase GSK3β and prevents GSK3β-dependent degradation of cyclin D3. The absence of K19 allowed active GSK3β to accumulate in the nucleus and degrade cyclin D3. Specifically, the head (H) domain of K19 was required to sustain inhibitory phosphorylation of GSK3β Ser9, prevent nuclear accumulation of GSK3β, and maintain cyclin D3 levels and cell proliferation. K19 was found to interact with GSK3β and K19-GSK3β interaction was mapped out to require Ser10 and Ser35 residues on the H domain of K19. Unlike wildtype K19, S10A and S35A mutants failed to maintain total and nuclear cyclin D3 levels and induce cell proliferation. Finally, we show that the K19-GSK3β-cyclin D3 pathway affected sensitivity of cells toward inhibitors to cyclin-dependent kinase 4 and 6 (CDK4/6). Overall, these findings establish a role for K19 in the regulation of GSK3β-cyclin D3 pathway and demonstrate a potential strategy for overcoming resistance to CDK4/6 inhibitors.

摘要

周期蛋白 D3 调节 G1/S 期转换,在包括乳腺癌在内的几种癌症类型中经常过表达,它促进肿瘤进展。在这里,我们表明细胞骨架蛋白角蛋白 19(K19)与丝氨酸/苏氨酸激酶 GSK3β 物理相互作用,并阻止 GSK3β 依赖性的 cyclin D3 降解。K19 的缺失允许活性 GSK3β 在核内积累并降解 cyclin D3。具体而言,K19 的头部(H)结构域需要维持 GSK3β Ser9 的抑制性磷酸化,防止 GSK3β 在核内积累,并维持 cyclin D3 水平和细胞增殖。发现 K19 与 GSK3β 相互作用,并且 K19-GSK3β 相互作用需要 K19 的 H 结构域上的 Ser10 和 Ser35 残基。与野生型 K19 不同,S10A 和 S35A 突变体未能维持总和核 cyclin D3 水平并诱导细胞增殖。最后,我们表明 K19-GSK3β-cyclin D3 途径影响细胞对细胞周期蛋白依赖性激酶 4 和 6(CDK4/6)抑制剂的敏感性。总体而言,这些发现确立了 K19 在 GSK3β-cyclin D3 途径调控中的作用,并展示了克服 CDK4/6 抑制剂耐药性的潜在策略。

相似文献

1
Keratin 19 interacts with GSK3β to regulate its nuclear accumulation and degradation of cyclin D3.角蛋白 19 与 GSK3β 相互作用,调节其核内积累和细胞周期蛋白 D3 的降解。
Mol Biol Cell. 2021 Nov 1;32(21):ar21. doi: 10.1091/mbc.E21-05-0255. Epub 2021 Aug 18.
2
Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors.角蛋白 19 调节细胞周期途径和乳腺癌细胞对 CDK 抑制剂的敏感性。
Sci Rep. 2019 Oct 10;9(1):14650. doi: 10.1038/s41598-019-51195-9.
3
Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells.胰岛素样生长因子I促使细胞周期蛋白D1在MCF-7S乳腺癌细胞中发生核内积聚。
J Biol Chem. 2002 Dec 6;277(49):47645-52. doi: 10.1074/jbc.M208727200. Epub 2002 Oct 2.
4
A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes.甲状腺细胞环磷酸腺苷依赖性增殖中细胞周期蛋白D3-细胞周期蛋白依赖性激酶(cdk)-4组装的必要性。
J Cell Biol. 1998 Mar 23;140(6):1427-39. doi: 10.1083/jcb.140.6.1427.
5
Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).转化生长因子β(1)通过阻止细胞周期蛋白D3-细胞周期蛋白依赖性激酶4与细胞核p27(kip1)的结合,选择性抑制原代甲状腺上皮细胞的环磷酸腺苷依赖性增殖。
Mol Biol Cell. 2000 Mar;11(3):1061-76. doi: 10.1091/mbc.11.3.1061.
6
Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.D1型、D3型、E型和A型细胞周期蛋白 - 细胞周期蛋白依赖性激酶复合物对T - 47D人乳腺癌细胞底物的差异磷酸化作用。
J Biol Chem. 1997 Dec 26;272(52):33327-37. doi: 10.1074/jbc.272.52.33327.
7
Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E.Cyclin D3 对于人弥漫性大 B 细胞淋巴瘤的存活和生长并非必需的:与 cyclin E 冗余的证据。
Cell Cycle. 2010 Feb 15;9(4):820-8. doi: 10.4161/cc.9.4.10783. Epub 2010 Mar 2.
8
The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration.糖原合成酶激酶3β随年龄增长而出现的活性下降在抑制肝脏再生中起关键作用。
Mol Cell Biol. 2009 Jul;29(14):3867-80. doi: 10.1128/MCB.00456-09. Epub 2009 Apr 27.
9
Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.组蛋白去乙酰化酶抑制剂曲古抑菌素A可诱导MCF-7乳腺癌细胞中泛素依赖性细胞周期蛋白D1降解。
Mol Cancer. 2006 Feb 20;5:8. doi: 10.1186/1476-4598-5-8.
10
GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells.GSK3β 依赖性细胞周期蛋白 D1 和细胞周期蛋白 E1 的降解对于 NVP-BEZ235 诱导神经母细胞瘤细胞 G0/G1 期阻滞是必不可少的。
Cell Cycle. 2017;16(24):2386-2395. doi: 10.1080/15384101.2017.1383577. Epub 2017 Nov 14.

引用本文的文献

1
Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications.细胞角蛋白在乳腺癌中的表达:从机制、进展、诊断、预后到治疗意义
Mol Cell Oncol. 2025 Jul 1;12(1):2526230. doi: 10.1080/23723556.2025.2526230. eCollection 2025.
2
Molecular docking analysis of triterpenoids from with breast cancer targets.来自[具体来源未给出]的三萜类化合物与乳腺癌靶点的分子对接分析。
Bioinformation. 2023 Nov 30;19(11):1067-1074. doi: 10.6026/973206300191067. eCollection 2023.
3
Keratin 19 binds and regulates cytoplasmic HNRNPK mRNA targets in triple-negative breast cancer.

本文引用的文献

1
GSK3 Inhibits Macropinocytosis and Lysosomal Activity through the Wnt Destruction Complex Machinery.GSK3 通过 Wnt 破坏复合物机制抑制巨胞饮作用和溶酶体活性。
Cell Rep. 2020 Jul 28;32(4):107973. doi: 10.1016/j.celrep.2020.107973.
2
Morphology, Motility, and Cytoskeletal Architecture of Breast Cancer Cells Depend on Keratin 19 and Substrate.乳腺癌细胞的形态、运动性和细胞骨架结构取决于角蛋白 19 和底物。
Cytometry A. 2020 Nov;97(11):1145-1155. doi: 10.1002/cyto.a.24011. Epub 2020 Apr 14.
3
Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors.
角蛋白 19 在三阴性乳腺癌中结合并调节细胞质 HNRNPK mRNA 靶标。
BMC Mol Cell Biol. 2023 Aug 17;24(1):26. doi: 10.1186/s12860-023-00488-z.
角蛋白 19 调节细胞周期途径和乳腺癌细胞对 CDK 抑制剂的敏感性。
Sci Rep. 2019 Oct 10;9(1):14650. doi: 10.1038/s41598-019-51195-9.
4
Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysis.细胞周期蛋白D3表达在恶性肿瘤患者中的预后意义:一项荟萃分析。
Cancer Cell Int. 2019 Jun 10;19:158. doi: 10.1186/s12935-019-0865-3. eCollection 2019.
5
Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin.中间丝作为癌症发展和转移的效应子:以角蛋白、波形蛋白和巢蛋白为例。
Cells. 2019 May 23;8(5):497. doi: 10.3390/cells8050497.
6
GSK3-β promotes calpain-1-mediated desmin filament depolymerization and myofibril loss in atrophy.GSK3-β 促进钙蛋白酶-1 介导的中间丝去聚合和萎缩时肌原纤维的丢失。
J Cell Biol. 2018 Oct 1;217(10):3698-3714. doi: 10.1083/jcb.201802018. Epub 2018 Jul 30.
7
Types I and II Keratin Intermediate Filaments.Ⅰ型和Ⅱ型角蛋白中间丝。
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):a018275. doi: 10.1101/cshperspect.a018275.
8
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib.基因组重排激活 D 型细胞周期蛋白与对 CDK4 和 CDK6 抑制剂阿贝西利的敏感性增强相关。
Cancer Cell. 2017 Dec 11;32(6):761-776.e6. doi: 10.1016/j.ccell.2017.11.006.
9
AKT/PKB Signaling: Navigating the Network.AKT/蛋白激酶B信号传导:探索该网络
Cell. 2017 Apr 20;169(3):381-405. doi: 10.1016/j.cell.2017.04.001.
10
Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway.细胞角蛋白 19 头区与 HER2 在细胞质中的相互作用导致 HER2-Erk 通路的激活。
Sci Rep. 2016 Dec 23;6:39557. doi: 10.1038/srep39557.